---
layout: entry
title: "Impact of COVID-19 related healthcare crisis on treatments for patients with lysosomal storage disorders, the first Italian experience"
link: "https://doi.org/10.1016/j.ymgme.2020.04.002"
author:
- Annalisa, Sechi; Daniela, Macor; Serena, Valent; Maria, Da Riol Rosalia; Manuela, Zanatta; Alessandro, Spinelli; Katja, Bianchi; Nadia, Bertossi; Andrea, Dardis; Francesca, Valent; Maurizio, Scarpa

summary:
- "no proved COVID-19 emerged among 102 interviewed. No problems were reported by patients receiving oral treatments. Forty-nine% of patients receiving enzyme replacement therapy experienced disruptions. The main reasons of missed infusions were fear of infection. re-organization of the infusion centers (37%) was a factor in the pandemic. Patients with lysosomal storage disorders receiving therapy. Infusion centers were reorganized."

original:
- "The direct and indirect effects of Coronavirus Disease-19 (COVID-19) pandemic, on Italian patients with lysosomal storage disorders receiving therapy, were analyzed by a phone questionnaire. No proved COVID-19 emerged among 102 interviewed. No problems were reported by patients receiving oral treatments. Forty-nine% of patients receiving enzyme replacement therapy in hospitals experienced disruptions, versus 6% of those home-treated. The main reasons of missed infusions were fear of infection (62.9%) and re-organization of the infusion centers (37%)."
---

